Trending at Lumira Ventures

Aurinia Appoints New Chief Commercial Officer & Expands U.S. Leadership

Jennifer Schram Aurinia Pharmaceuticals, Portfolio News

VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the appointment of Max Colao to the newly created position of Chief Commercial …